Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in sprague-dawley rats

Carcinogenesis

Volumn 15, Issue 12, 1994, Pages 2847-2850

  Chen, Hui ^a   Huang, Cheng yu ^a   Wilson, Mary W ^a   Lay, L Travis ^a   Robertson, Larry W ^b   Chow, Ching K ^a,b   Glauert, Howard P ^a,b  

^a Department of Nutrition and Food Science ^*  (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CIPROFIBRATE; PERFLUORODECANOIC ACID; PEROXISOME PROLIFERATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; ENZYME ACTIVITY; FEMALE; LIVER CELL; LIVER TOXICITY; NONHUMAN; OSMOTIC MINIPUMP; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT;

ANIMAL; CELL DIVISION; CLOFIBRIC ACID; DECANOIC ACIDS; DNA DAMAGE; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROCARBONS; LIVER; LIVER REGENERATION; MALE; MICROBODIES; OXIDATION-REDUCTION; OXIDOREDUCTASES; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028575799     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/15.12.2847     Document Type: Article

References (32)

1. Reddy, J.K. and Lalwani, J.l.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. ToxicoL, 12, 1-58.
2. Conway, J.G., Cattley, R.C., Popp, J.A. and Butterworth, B.E. (1989) Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2- ethylhexyl)phthalate. Drug Metab. Rev., 21, 65-102.
3. Guenthner, R.A. and Vietor, L.M. (I%2) Surface active materials from perfluorocarboxylic and perfluorosulfonic acids. Ind. Engng. Chem. Prod. Res. Dev., 1, 165-169.
4. George, M.E. and Andersen, M.E. (1986) Toxic effects of nonadecafluoro- n-decanoic acid in rats. Toxicol. AppL Pharmacol., 85, 169-180.
5. Borges, T., Glauert, H.P, Chen, L.-C., Chow, C.K. and Robertson, L.W. (1990) Effect of the peroxisome proliferator perfluorodecanoic acid on growth and lipid metabolism in Sprague Dawley rats fed three dietary levels of selenium. Arch. Toxicol., 64, 26-30.
6. Borges, T., Robertson, L.W., Peterson, R.E. and Glauert, H.P. (1992) Dose- related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal beta-oxidation. Arch. ToxicoL, 66, 18-22.
7. Van Rafelghem, MJ., Vanden Heuvel, J.P., Menahan, L.A. and Peterson, R.E. (1988) Perfluorodecanoic acid and lipid metabolism in the rat. Lipids, 23, 671-678.
8. Harrison, E.H., Lane, J.S., Luking, S., Van Rafelghem.MJ. and Andersen, M.E. (1988) Perfluoro-n-decanoic acid: Induction of peroxisomal beta- oxidation by a fatty acid with dioxin-like toxicity. Lipids, 23, 115-119.
9. Van Rafelghem, MJ., Noren, C.W., Menahan, L.A. and Peterson, R.E. (1988) Interrelationships between energy and fat metabolism and hypophagia in rats treated with perfluorodecanoic acid. ToxicoL Lett., 40, 57-69.
10. Ikeda, T., Aiba, K., Fukuda, K. and Tanaka, M. (1985) The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J. Biochem., 98, 475-482.
11. Van Rafelghem, M.J., Inhom, S.L. and Peterson, R.E. (1987) Effects of perfluorodecanoic acid on thyroid status in rats. ToxicoL AppL Pharmacol., 87, 430-439.
12. Langley, A. E. and Pilcher, G.D. (1985) Thyroid, bradycardic, and hypothermic effects of perfluorodecanoic acid in rats. J. ToxicoL Environ. Health, 15, 485-491.
13. Boiges, T., Glauert, H.P. and Robertson, L.W. (1993) Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase. ToxicoL AppL Pharmacol., 118, 8-15.
14. Borges, T., Peterson, R.E., Pitot, H.C., Robertson, L.W. and Glauert, H.P. (1993) Effect of the peroxisome proliferator perfluorodecanoic acid on the promotion of 2-stage hepatocarcinogenesis in rats. Cancer Lett., 72, 111-120.
15. Hawkins, J.M., Jones, W.E., Bonner, F.W. and Gibson, G.G. (1987) The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab. Rev., 18, 441-515.
16. Bentley, P, Bieri, F., Muakkassah-Kelly, S., Stflubli, W. and Waechter, F. (1988) Mechanisms of tumor inducUon by peroxisome proliferators. Arch. ToxicoL, SuppL, 12, 240-247.
17. Marsman, D.S., Cattley, R.C., Conway, J.G. and Popp, J.A. (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2, 3-xylidino)-2-pyrimidinyl- thio]acedc acid (Wy-14, 643) in rats. Cancer Res., 48, 6739-6744.
18. Yager J.D., Roebuck, B.D., Paluszcyk, T.L. and Memoli, V.A. (1986) Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis, 7, 2007-2014.
19. Goldsworthy, T.L„ Morgan, K., Popp, J. and Butterworth, B. (1989) Measurement of chemically-induced cell proliferadon in specific rodent target organs. Technical Notes for the CUT Workshop on Cell Replication. Chemical Industry Institute of Toxicology, Research Triangle Park, NC.
20. Eldridge, S.R., Tilbury, T.F., Goldsworthy, T.L. and Butterworth, B.E. (1990) Measurement of chemically induced cell proliferadon in rodent liver and kidney: A comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump. Carcinogenesis, 11, 2245-2251.
21. Higgins, G.M. and Anderson, R.M. (1931) Experimental pathology of the liven restoration of the liver of the white rat following partial surgical removal. Arch. Pathol., 12, 186-202.
22. Vanden Heuvel, J.P., Kuslikis, B.I., Van Rafelghem MJ. and Peterson, R.E. (1991) Disposition of perfluorodecanoic acid in male and female rats. ToxicoL AppL Pharmacol., 107, 450459.
23. Cayen, M.N. (1983) Metabolism and pharmacokinedcs of anti- hyperlipidaemic agents. Prog. Drug Metab., 7, 173-227.
24. Poosch, M.S., and Yamazaki, R.K. (1986) Determination of peroxisomal fatty acyl-CoA oxidase aedvity using a lauroyl-CoA-based fluorometric assay. Biochim. Biophys. Acta, 884, 585-593.
25. Lowry, O.H., Rosebrough, NJ., Farr, A.L. and Randall, RJ. (1951) Protein measurement with the Folin phenol reagent. J. Biot. Chem., 193, 265-275.
26. Althaus, F.R., Lawrence, S.D., Saltier, G.L. and Pitot, H.C. (1980) The effect of nicotinamide on unscheduled DNA synthesis in cultured hepatocytes. Biochem. Biophys. Res. Commun., 95, 1063-1070.
27. Lentner, M. and Bishop, T. (1986) Experimental Design and Analysis. Valley Books, Blacksbutg, VA.
28. Eacho, P.I., Lanier, T.L. and Brodhecker, C.A. (1991) Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of WY-14, 643 to clofibric acid, nafenopin and LY171883. Carcinogenesis, 12, 1557-1561.
29. Yeldandi, A.V., Milano, M., Subbarao, V., Reddy, J.K. and Rao, M.S. (1989) Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett., 47, 21-27.
30. Issemann, J. and Green, S. (1990) AcUvadon of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650.
31. Schulte-Hermann, R., Ohde, G., Schuppler, J. and Timmermann-Troisener, I. (1981) Enhanced proliferadon of putative preneoplasdc cells in rat liver following treatment with tumor promoters phenobarbital, hexachloro- cyclohexane, steroid compounds, and nafenopin. Cancer Res., 41, 2556-2562.
32. Grasl-Kraupp, B., Huber, W., Just, W., Gibson, G. and Schulte-Hermann, R. (1993) Enhancement of peroxisomal enzymes, cytochrome P452 and DNA synthesis in putative preneoplasdc foci of rat liver treated with the peroxisome proliferator nafenopin. Carcinogenesis, 14, 1007-1012.